FAAH inhibitor

This is part of heta-lang project.

This is Quantitative Systems Pharmacology (QSP) modeling platform describing Fatty Acid Amide Hydrolase inhibition in human.

Model history

The human model of FAAH inhibition was developed by InSysBio and Pfizer in 2012 to support the analysis of clinical data on perspective pain killer PF‐04457845.
The model was published in CPT: Pharmacokinetics & Systems Pharmacology journal in 2014.
The SBML code of the model was published on BioModels Database in 2014 under CC0 license.
In January 2016 it was model of the month of BioModels Database
In 2019 the model was published on GitHub as QSP modeling platform in Heta notation.

(c) InSysBio 2019-2021

Name		Name	Last commit message	Last commit date
Latest commit History 32 Commits
.github/workflows		.github/workflows
R		R
julia		julia
src		src
static		static
.gitignore		.gitignore
.travis.yml		.travis.yml
CHANGELOG.md		CHANGELOG.md
LICENSE		LICENSE
README.md		README.md
platform.json		platform.json